Hunan Hansen Pharmaceutical Co., Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was CNY 887.490 million compared to CNY 921.949 million a year ago. Operating income was CNY 187.636 million compared to CNY 166.233 million a year ago. Net income was CNY 162.377 million compared to CNY 147.536 million a year ago. Basic earnings per share from continuing operations was CNY 0.3227 compared to CNY 0.2932 a year ago.